We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
-23.9%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$302M
AUM Growth
-$151M
Cap. Flow
-$16.4M
Cap. Flow %
-5.44%
Top 10 Hldgs %
49.77%
Holding
317
New
38
Increased
51
Reduced
65
Closed
64

Top Buys

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$3.72M
2
SHOP icon
Shopify
SHOP
+$3.18M
3
ADSK icon
Autodesk
ADSK
+$3.15M
4
CRM icon
Salesforce
CRM
+$2.94M
5
HTZWW
Hertz Global Holdings Warrants
HTZWW
+$2.55M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$9.48M
2
ARGX icon
argenx
ARGX
+$4.12M
3
SE icon
Sea Limited
SE
+$3.9M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$3.16M
5
CHRD icon
Chord Energy
CHRD
+$3.12M

Sector Composition

Rank Sector Weight
1 Technology 27.72%
2 Healthcare 26.86%
3 Miscellaneous 22.85%
4 Communication Services 13.94%
5 Consumer Discretionary 5.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADSK icon
26
Autodesk
ADSK
$55B
$3.15M 1.05%
18,350
+16,400
+841% +$3.15M
ARGX icon
27
argenx
ARGX
$64B
$3.11M 1.03%
8,208
-12,801
-61% -$4.12M
MRNA icon
28
Moderna
MRNA
$55.1B
$2.96M 0.98%
20,700
+15,700
+314% +$2.24M
COIN icon
29
Coinbase
COIN
$47.1B
$2.82M 0.93%
60,000
+8,500
+17% +$809K
STNE icon
30
StoneCo
STNE
$2.24B
$2.73M 0.91%
355,000
+30,000
+9% +$287K
MGA icon
31
Magna International
MGA
$17.6B
$2.06M 0.68%
37,500
+15,000
+67% +$914K
MSFT icon
32
Microsoft
MSFT
$3.81T
$2.06M 0.68%
+8,000
New +$2.17M
ESSC
33
DELISTED
East Stone Acquisition Corporation Ordinary Shares
ESSC
$1.82M 0.6%
177,672
-22,800
-11% -$238K
NVDA icon
34
NVIDIA
NVDA
$5.25T
$1.64M 0.54%
+108,100
New +$2.04M
XYZ
35
Block Inc
XYZ
$50.2B
$1.56M 0.52%
25,377
+8,900
+54% +$813K
ALNY icon
36
Alnylam Pharmaceuticals
ALNY
$31.7B
$1.53M 0.51%
10,500
+5,000
+91% +$709K
ACN icon
37
Accenture
ACN
$116B
$1.46M 0.48%
+5,250
New +$1.58M
NBIX icon
38
Neurocrine Biosciences
NBIX
$15.7B
$1.34M 0.44%
13,732
– –
TMO icon
39
Thermo Fisher Scientific
TMO
$230B
$1.27M 0.42%
2,337
+1,087
+87% +$598K
FFAIW
40
DELISTED
Faraday Future Intelligent Electric Warrant
FFAIW
$1.19M 0.4%
2,552,064
-51,974
-2% -$23.5K
JOBY.WS
41
DELISTED
Joby Aviation Warrants
JOBY.WS
$1.16M 0.39%
1,070,581
-153,696
-13% -$194K
AMPL icon
42
Amplitude
AMPL
$1.79B
$1.1M 0.36%
77,000
+27,000
+54% +$474K
TSLA icon
43
Tesla
TSLA
$1.38T
$1.01M 0.33%
+4,500
New +$1.23M
ZM icon
44
Zoom
ZM
$28.7B
$1.01M 0.33%
+9,350
New +$986K
CELUW
45
DELISTED
Celularity Inc
CELUW
$995K 0.33%
1,723,027
+51,595
+3% +$50.8K
BBAI.WS icon
46
BigBear.ai Holdings Warrant
BBAI.WS
$18.8M
$958K 0.32%
2,394,126
+219,271
+10% +$173K
AMAT icon
47
Applied Materials
AMAT
$366B
$945K 0.31%
+10,390
New +$1.14M
GPK icon
48
Graphic Packaging
GPK
$3.42B
$923K 0.31%
45,000
– –
OWL.WS
49
DELISTED
Blue Owl Capital Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A C
OWL.WS
$830K 0.28%
404,765
+148,257
+58% +$461K
OPAD.WS
50
DELISTED
Offerpad Solutions Inc. Warrants, Every 15 warrants will be exercisable for one share of Class A Common Stock at an exercise price of $172.50 per share of Class A Common Stock
OPAD.WS
$826K 0.27%
3,216,000
+117,565
+4% +$72.7K
1
2
3 4 5

Similar funds

RWMH
Riverpoint Wealth Management Holdings Chicago, Illinois $544M AUM 20.39% 1-Year Est. Return
BPIA
Broad Peak Investment Advisers Singapore $544M AUM 132.56% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $544M AUM 70.51% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $544M AUM 40.38% 1-Year Est. Return
FIM
FWL Investment Management Dallas, Texas $545M AUM 64.06% 1-Year Est. Return
DKAM
Drummond Knight Asset Management Crows Nest, NSW, Australia $545M AUM 73.62% 1-Year Est. Return
CCM
Coerente Capital Management Toronto, Ontario, Canada $543M AUM 7.53% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Privium Fund Management's Q2 2022 Portfolio in Review

As of Q2 2022, Privium Fund Management held 317 positions worth $302M, down 33% from $452M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Privium Fund Management withdrew a net $16.4M in Q2 2022, closing 64 positions and reducing 65 holdings. Its most notable exit was Royalty Pharma, an estimated $9.48M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Miscellaneous.

Against the trend, Privium Fund Management opened a new position in Microsoft worth $2.06M.

  • Privium Fund Management's largest Q2 2022 buy was Microsoft: 8,000 shares worth $2.06M.
  • Privium Fund Management added most to Snowflake in Q2 2022, an estimated $3.72M increase.
  • Privium Fund Management's biggest Q2 2022 reduction was argenx, cutting an estimated $4.12M.
  • Privium Fund Management fully exited Royalty Pharma in Q2 2022, selling an estimated $9.48M.
  • Privium Fund Management's ten largest holdings make up 50% of its $302M portfolio in Q2 2022.
  • Privium Fund Management opened 38 new positions and closed 64 in Q2 2022.
  • Privium Fund Management's portfolio value fell 33% quarter-over-quarter to $302M.

Based on Privium Fund Management's 13F filing for Q2 2022, filed 28 Jul 2022.